Pfizer Worldwide Research and Development , 700 Main Street, Cambridge, Massachusetts 02139, United States.
J Med Chem. 2013 Sep 12;56(17):6819-28. doi: 10.1021/jm4006324. Epub 2013 Aug 28.
Casein kinase 1δ (CK1δ) and 1ε (CK1ε) are believed to be necessary enzymes for the regulation of circadian rhythms in all mammals. On the basis of our previously published work demonstrating a CK1ε-preferring compound to be an ineffective circadian clock modulator, we have synthesized a series of pyrazole-substitued pyridine inhibitors, selective for the CK1δ isoform. Additionally, using structure-based drug design, we have been able to exploit differences in the hinge region between CK1δ and p38 to find selective inhibitors that have minimal p38 activity. The SAR, brain exposure, and the effect of these inhibitors on mouse circadian rhythms are described. The in vivo evaluation of these inhibitors demonstrates that selective inhibition of CK1δ at sufficient central exposure levels is capable of modulating circadian rhythms.
酪蛋白激酶 1δ(CK1δ)和 1ε(CK1ε)被认为是所有哺乳动物生物钟调节所必需的酶。基于我们之前发表的工作,证明 CK1ε 优先的化合物是一种无效的生物钟调节剂,我们已经合成了一系列吡唑取代的吡啶抑制剂,对 CK1δ 同工型具有选择性。此外,我们还利用基于结构的药物设计,利用 CK1δ 和 p38 之间铰链区域的差异,找到了对 p38 活性最小的选择性抑制剂。描述了这些抑制剂的 SAR、脑暴露和对小鼠生物钟的影响。这些抑制剂的体内评估表明,在足够的中枢暴露水平下选择性抑制 CK1δ 能够调节生物钟。